Earwax removal and microsuction clinic marketing

Earwax removal has become a service of its own. Hearing clinics, ENT offices, primary care practices, pharmacies, nurse-led clinics and mobile providers now advertise “microsuction,” “safe, gentle wax removal” and same-day appointments, and short videos of wax coming out of an ear canal draw large audiences. The demand is real: the clinical guideline on earwax describes it as one of the most common reasons people seek care for an ear problem. The marketing still has to match what that guideline and federal law say.

This guide is for practices and clinics that offer cerumen (earwax) removal by irrigation, suction or instruments. It covers who the clinical guideline says should be treated, what you can say about methods and safety, how to talk about ear candles and home kits, FDA device wording, wax removal videos, and pricing. We do not name any clinic, device or product. If you also treat ringing in the ears, read our guide to tinnitus clinic marketing; for hearing tests and hearing aids, see audiology and hearing aid practice marketing.

The short version

• Not everyone needs wax removed. The AAO-HNSF guideline says clinicians should not routinely treat cerumen in people who have no symptoms and whose ears can be examined. “Everyone should have their ears cleaned every six months” runs against that.
• No method is proven best. The guideline lists irrigation, softening drops and manual removal (including suction) as options and says evidence that one is superior is lacking. “Microsuction is the safest method” needs evidence you probably do not have.
• Every method has risks. The guideline lists eardrum perforation, canal injury, infection, bleeding, dizziness and, for suction, rare tinnitus or hearing loss from the noise. “Risk-free” and “100% safe” are false.
• Ear candles: do not offer them. FDA warned consumers not to use ear candles and found no valid scientific evidence for any medical benefit, and the guideline recommends against candling.
• Device wording. Ear suction tubes and ear curettes are Class I devices exempt from 510(k) (21 CFR 874.4420). “FDA-approved microsuction” is wrong, and so is implying approval from registration (21 CFR 807.39).

What the clinical guideline says

The 2017 AAO-HNSF guideline is the main U.S. clinical reference on earwax, and it was written by a multidisciplinary panel that included a consumer representative. Points that bear on marketing:

• Cerumen impaction is defined as an accumulation of cerumen that causes symptoms, prevents needed examination of the ear, or both. Wax alone is not a condition that needs treatment.
• Earwax is normally cleared by a self-cleaning mechanism in which it migrates out of the ear canal, helped by jaw movement.
• Excessive or impacted cerumen is present in 1 in 10 children, 1 in 20 adults and more than one-third of older adults and people with developmental delays, according to the studies the guideline cites.
• The guideline cites estimates that about 12 million people in the United States seek care for problematic cerumen each year, leading to nearly 8 million removal procedures.
• Clinicians should check for factors that change how wax is managed: anticoagulant therapy, a weakened immune system, diabetes, prior head and neck radiation, a narrow ear canal, bony growths in the canal (exostoses) and a non-intact eardrum.
• Clinicians should look for blocking wax in people who may not be able to report symptoms, such as young children and cognitively impaired children and adults, and should check the ears of hearing aid users during health care visits.
• After in-office removal, clinicians should examine the ear, document that the impaction is resolved, and look for other causes if symptoms continue.

Two marketing points follow. First, the honest offer is removal when wax causes symptoms or blocks an exam, not routine cleaning for everyone. Second, a page that describes a quick look, the removal and a check afterward matches the guideline better than a page that only sells speed.

Who performs it, and how to say so

The guideline says the training, skill and experience of the clinician play a significant role in which method is used. It also says that, depending on state scope-of-practice laws, the check after treatment may be done by a physician, audiologist, advanced practice nurse, physician assistant or registered nurse, and that scope rules for medical assistants vary by state.

• Name the actual credential of the person who does the procedure on your booking page: “performed by a registered nurse” or “by our audiologist,” not a made-up title such as “ear care specialist” or “certified ear technician” that implies a license the person does not hold.
• If staff completed a training course, say what it was. Do not present a private course certificate as a state license or board certification.
• Mobile and home-visit services should say who comes to the home, what equipment they bring and what happens if they find something other than wax, such as signs of infection or a perforated eardrum.
• Before you advertise that a hearing aid dispenser, medical assistant or other team member removes wax, confirm your state allows it. We did not read state rules and do not list which states permit what.

Method and safety claims

Under the FTC Act, an ad is deceptive if its net impression misleads, and health and safety claims need competent and reliable scientific evidence (15 USC 45 and 52; FTC Health Products Compliance Guidance). Compare what the guideline supports with common ad copy:

• “Safest method” or “better than syringing.” The guideline says there are no comparative randomized trials of the three main methods and that it does not name one method as superior. A comparative claim needs comparative evidence.
• “Painless” and “no risk.” The guideline reports that injury, infection, bleeding or hearing loss occurs in about 1 in 1,000 ear irrigations, and its patient table lists discomfort and noise from suction and rare tinnitus or hearing loss from that noise. You can say most people find it comfortable if your own records support it. Do not say it cannot hurt or cannot cause harm.
• “No water, so no infection.” Manual and suction removal also carry a risk of canal trauma that can lead to infection, per the guideline. Describe what you avoid, without promising an outcome.
• “Restores your hearing.” The guideline’s patient answers say that when the ear canal is completely or almost completely blocked, removal lets hearing return to the level it was before the blockage. It does not treat hearing loss from other causes. Say “if wax is blocking your ear canal” and offer a hearing test for anything else.
• Tinnitus, dizziness and ear pain. Wax can be one cause, but these symptoms have many causes. If symptoms continue after removal, the guideline says to look for other diagnoses. Do not list them as things wax removal will fix.

Write a short “who should not book online” note as well. The guideline says irrigation and softening drops should not be used when the eardrum is not intact. People with ear tubes, a known hole in the eardrum, recent ear surgery, ear discharge or sudden hearing loss should be told to call first or see a doctor.

Routine cleaning and membership offers

Subscription and “ear health plan” offers are common. The guideline recommends against routinely treating wax in people without symptoms whose ears can be examined, and its patient answers say most people do not need a regular schedule to prevent buildup.

• A plan for people who build up wax repeatedly, such as some hearing aid users, can be described honestly: “for patients who need removal more than once a year.”
• Do not market six-monthly cleaning to everyone as preventive care, and do not imply that untreated wax will damage hearing over time if the person has no symptoms.
• State what a plan includes, how to cancel and whether unused visits carry over. A low monthly price that hides a sign-up fee or a long minimum term misleads (15 USC 45).

Ear candles, home kits and products you sell

Clinics often compare themselves with home methods. Those comparisons should be accurate too.

• Ear candles. FDA warned consumers not to use ear candles because they can cause serious injuries even when used as directed, and said it found no valid scientific evidence of their safety or effectiveness for any medical claim. The guideline recommends against ear candling. Do not offer candling or “thermo-auricular therapy” next to medical removal.
• Cotton swabs and oral jet irrigators. The guideline lists home use of oral jet irrigators and cotton-tipped swabs as interventions that are not appropriate for removing wax. You can say that, and cite it.
• Home suction and camera kits. The guideline cites one nonrandomized comparison in which a clinician’s probe removed wax more effectively than a do-it-yourself ear vacuum. That is one small study. “Home kits never work” or “home kits cause deafness” overstates it.
• Self-irrigation. The guideline also reports studies in which patients given drops and a bulb syringe at home had comparable outcomes to those treated by a provider. If your marketing says home care is always dangerous, it contradicts the guideline you are relying on.
• Drops you sell. Over-the-counter earwax removal aids are covered by 21 CFR 344. The listed active ingredient is carbamide peroxide 6.5% in anhydrous glycerin, the label indication is “for occasional use as an aid to soften, loosen, and remove excessive earwax,” and the label says not to use it for more than 4 days and to consult a doctor for children under 12. Shelf talkers and web copy should not promise more than that.

FDA wording for suction, curettes and otoscopes

Most equipment used for wax removal sits in Class I. Under 21 CFR 874.4420, ear suction tubes, ear curettes, ear spoons and ear excavators are Class I and exempt from 510(k) premarket notification. Irrigating syringes are Class I and 510(k)-exempt under 21 CFR 880.6960, and otoscopes are Class I and exempt under 21 CFR 874.4770 when used in the external ear canal. FDA’s data list an “ear irrigation kit” product code (OGQ) under 880.6960 with no 510(k) clearances, and 5 clearances for ear suction tubes (JZF) as of November 1, 2026.

• Do not say “FDA-approved microsuction” or “FDA-approved equipment.” These devices are not approved, and most are not individually cleared either.
• “FDA-cleared” is accurate only for a device that actually has a 510(k) clearance, and only for its cleared use. Under 21 CFR 807.97, even a clearance does not denote official approval.
• “FDA-registered” says little about safety. Under 21 CFR 807.39, registration does not denote approval of the establishment or its products, and a representation that creates that impression is misleading.
• Describe your setup in plain terms: “we use an operating microscope so we can see the ear canal during removal.” That is a factual claim you can support.

Wax removal videos and reviews

Before-and-after wax videos are a large part of this market. They raise privacy and endorsement issues:

• A clip of an ear canal is a record of patient care. If the video, voice, caption, tag or comments can identify the patient, treat it as protected health information and get a signed HIPAA authorization before you post it. Our guide to patient photo consent for marketing covers what the form needs.
• Pick ordinary cases or say they are not typical. Under 16 CFR 255.2(b), an ad that shows a dramatic result is likely to be read as typical unless it clearly discloses the generally expected results.
• Under 16 CFR 255.2(a), you are responsible for what a patient review conveys. “I could hear perfectly again” or “my tinnitus disappeared” are outcome claims you would need to support.
• Under 16 CFR 255.5, disclose any material connection with someone who promotes you, such as a creator who received a free removal for a video or a referral source who gets paid.

Our guide to patient testimonials and before-and-after photos covers the wider rules on reviews and images.

Prices and insurance wording

• Say whether the price is per ear or both ears, and whether a repeat visit is included if the wax does not come out the first time. The guideline expects some people to need softening drops first or additional treatment.
• If a consultation fee applies when no removal is needed, say so before booking.
• Do not tell patients that insurance never covers earwax removal to steer them to cash pay. The guideline notes that Medicare spent nearly $50 million on cerumen-related procedures in 2012. If you do not bill insurance, say that, and say patients can ask their insurer about coverage.

For more on cash prices in ads, see our guide to advertising cash prices.

Checklist for an earwax removal page or ad

• Removal offered for wax that causes symptoms or blocks an exam, not routine cleaning for everyone (AAO-HNSF 2017).
• No “safest method” or “better than” claims without comparative evidence.
• No “painless,” “no risk” or “restores hearing” promises; risks named honestly.
• A clear note telling people with ear tubes, a perforated eardrum, recent ear surgery, discharge or sudden hearing loss to call first.
• The real credential of the person performing removal, checked against your state’s rules.
• No ear candling, and accurate comparisons with home methods.
• No “FDA-approved” or “FDA-registered” claims for equipment (21 CFR 807.39, 807.97).
• Drops sold within the 21 CFR 344 indication and warnings.
• Signed authorization for identifiable videos; typical results disclosed (16 CFR 255.2).
• Per-ear or per-visit price, repeat-visit terms and honest insurance wording.

How we help

We build websites and campaigns for hearing, ENT and primary care practices, with claims checked against the sources above: website design with clear booking pages and pre-visit notes, healthcare SEO for searches like “earwax removal near me,” and lead generation that routes people with red-flag symptoms to a phone call instead of an online slot. ENT practices should also read our guide to ENT and allergy practice marketing. We do not give legal or clinical opinions and we are not a law firm.

Sources

• AAO-HNSF: Clinical Practice Guideline (Update): Earwax (Cerumen Impaction), January 2017, PubMed
• Plain Language Summary: Earwax (Cerumen Impaction), January 2017, PubMed
• FDA: Advice for Patients: Ear Candles (Internet Archive copy)
• FDA: Don’t Get Burned: Stay Away From Ear Candles (February 18, 2010, Internet Archive copy)
• 21 CFR 344: Topical otic drug products for over-the-counter human use
• 21 CFR 874.4420: Ear, nose, and throat manual surgical instrument
• 21 CFR 874.4770: Otoscope
• 21 CFR 880.6960: Irrigating syringe
• 21 CFR 807.39: Misbranding by reference to establishment registration
• 21 CFR 807.97: Misbranding by reference to premarket notification
• FDA product classification: JZF (ear suction tube)
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• 16 CFR 255.5: Disclosure of material connections
• 15 USC 45: Unfair methods of competition unlawful
• 15 USC 52: Dissemination of false advertisements

More in Dental, vision, hearing and therapy marketing